Figure 4.
Annual changes in the proportions of the types of anticoagulation therapy (warfarin, edoxaban, rivaroxaban, apixaban, and others) among patients with anticoagulation therapy at discharge from 2012 to 2017.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.